Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD

Wasatch Advisors LP lifted its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 21.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,498,884 shares of the company’s stock after acquiring an additional 448,360 shares during the period. Wasatch Advisors LP owned 3.04% of Pediatrix Medical Group worth $63,297,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC raised its holdings in Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after purchasing an additional 1,365 shares in the last quarter. Transamerica Financial Advisors LLC purchased a new position in Pediatrix Medical Group during the fourth quarter valued at $30,000. Eurizon Capital SGR S.p.A. purchased a new position in Pediatrix Medical Group during the fourth quarter valued at $33,000. TD Private Client Wealth LLC bought a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at $39,000. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at $43,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Weiss Ratings raised shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, August 4th. UBS Group upped their price objective on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Finally, Truist Financial raised their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Two analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Pediatrix Medical Group has an average rating of “Hold” and a consensus target price of $24.83.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $26.20 on Wednesday. The business has a fifty day moving average price of $25.24 and a 200-day moving average price of $22.69. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.13 billion, a PE ratio of 12.54 and a beta of 0.66. Pediatrix Medical Group, Inc. has a 1-year low of $14.19 and a 1-year high of $27.94.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.59 by $0.04. The company had revenue of $487.78 million for the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. Pediatrix Medical Group’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.53 EPS. As a group, equities analysts expect that Pediatrix Medical Group, Inc. will post 2.13 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.